Xponance Inc. Sells 371 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Xponance Inc. lessened its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 1.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,829 shares of the company’s stock after selling 371 shares during the quarter. Xponance Inc.’s holdings in Bath & Body Works were worth $1,165,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. First Community Trust NA bought a new stake in Bath & Body Works during the second quarter worth about $30,000. GAMMA Investing LLC increased its stake in shares of Bath & Body Works by 75.7% in the first quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock valued at $56,000 after buying an additional 481 shares in the last quarter. TFO Wealth Partners LLC grew its holdings in Bath & Body Works by 9,664.7% during the 4th quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after acquiring an additional 1,643 shares during the last quarter. Quarry LP increased its holdings in shares of Bath & Body Works by 289.4% in the fourth quarter. Quarry LP now owns 1,690 shares of the company’s stock valued at $73,000 after purchasing an additional 1,256 shares in the last quarter. Finally, EntryPoint Capital LLC raised its position in shares of Bath & Body Works by 224.0% during the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after acquiring an additional 1,017 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on BBWI shares. Citigroup dropped their price target on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research note on Tuesday, August 20th. Raymond James lowered their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a research note on Monday, August 26th. JPMorgan Chase & Co. cut their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Finally, UBS Group reduced their price target on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and an average target price of $42.35.

Bath & Body Works Trading Up 2.0 %

BBWI opened at $32.39 on Friday. The stock has a market capitalization of $7.10 billion, a P/E ratio of 8.35, a PEG ratio of 0.96 and a beta of 1.77. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a 50-day moving average price of $31.85 and a 200-day moving average price of $40.31.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.47%. Bath & Body Works’s dividend payout ratio (DPR) is currently 20.62%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.